BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cancer / Immunology

World Cancer Day 2024: WHO Regional Director Urges Collective Action for a Cancer-Free Africa

The cancer situation in Africa is alarming, with 1.1 million new cases and 700,000 deaths in 2020. Breast, cervical, prostate, colorectal, and live...

February 04, 2024 | News

DELFi Diagnostics Launches Fragmentome-Based Cancer Treatment Monitoring Assay

DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, announced availability of the comp...

February 04, 2024 | News

ASPIRE Consortium Tackles Rising Lung Cancer in Asia-Pacific

Lung cancer has a significant health and economic impact in the region. It is the most prevalent cancer, accounting for about 1 million deaths per year, an...

February 04, 2024 | News

Genmab and Pfizer Announce European Medicines Agency Validation for Tisotumab Vedotin in Cervical Cancer

Genmab A/S (Nasdaq: GMAB) and Pfizer, Inc. (NYSE: PFE) have reported that the European Medicines Agency (EMA) has validated the marketing authorization app...

February 02, 2024 | News

RemeGen Spotlights Three Major Advances in Global Cancer Battle, Closing Care Gap

Dr. Jianmin Fang, CEO of RemeGen, commented, "Cancer is the common enemy of mankind, and at RemeGen we feel a strong sense of responsibility and missi...

February 02, 2024 | News

QIAGEN Digital Insights Introduces Rapid NGS Analysis for Somatic Cancer

New software accelerator significantly reduces time and cost of NGS secondary analysis for somatic cancer, analyzing a 275-gene comprehensive cancer pane...

February 02, 2024 | News

Biosyngen's BST02 Granted FDA Fast Track for Liver Cancer Treatment

Fast track is a process designed to facilitate development, and accelerate the review of drugs to treat serious or life-threatening conditions and fill an ...

February 02, 2024 | News

Agilent and Incyte Team Up for Advanced Diagnostics in Hematology & Oncology

The value of the companion diagnostics market is predicted to expand to nearly US $14B by 2030, driven in part by the power of these tests to inform t...

February 01, 2024 | News

CellVax Therapeutics Receives FDA Clearance for FK-PC101 Cancer Immunotherapy IND

FK-PC101 is CellVax's novel personalized cancer immunotherapy intended to treat prostate cancer patients who have a high risk of recurrence after prostatec...

January 30, 2024 | News

FDA Designates Amadix's Blood Test as Breakthrough Device for Colorectal Cancer Screening

PreveCol®, a blood test for oncological diagnosis, has obtained US recognition for its efficacy in detecting precancerous lesions compared to existin...

January 24, 2024 | Regulatory

AIM ImmunoTech Initiates Phase 1b/2 Trial for Ampligen® and AstraZeneca's Imfinzi® in Late-Stage Pancreatic Cancer

AIM ImmunoTech Inc. announced that the first subject has been enrolled at Erasmus Medical Center in a Phase 1b/2 clinical trial combining AIM&rs...

January 23, 2024 | News

Merck's JAVELIN Bladder Regimen Shines in Real-World Data, Elevating Standard Care for Urothelial Carcinoma

Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...

January 23, 2024 | News

AstraZeneca's IMFINZI Combo Shows Significantly Improved Survival in Liver Cancer

Positive results from the EMERALD-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with TACE and bevacizumab demo...

January 22, 2024 | News

BostonGene and Prisma Health Collaborate to Predict Immunotherapy Efficacy in Rare Cancers

BostonGene, a leading provider of AI-based molecular and immune profiling solutions provider, today announces a collaboration with Prisma Health aimed at a...

January 19, 2024 | News

Stay Connected